Keywords: Alzheimer's Disease, Alzheimer's Disease, Blood-brain barrier
Blood-brain-barrier (BBB) impairment is an important pathophysiological process in Alzheimer’s disease (AD). However, most neuroimaging methods assessing BBB function require contrast agent injection, limiting the methods’ application. Vascular-water-exchange imaging (VEXI), a version of filter-exchange imaging (FEXI), is a contrast-agent-free method assessing BBB permeability to water. We quantitatively measured BBB permeability using VEXI in normal subjects, mild cognitive impairment patients, and AD patients and found BBB breakdown occurred specifically in the hippocampus, worsening with disease progression. In addition, BBB permeability to water showed a significant correlation with cognitive impairment. Therefore, VEXI might be a potential contrast-agent-free neuroimaging method.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords